Editas Medicine, Inc. · GETTEX:8EM

Editas Medicine, Inc. financial statements

Editas Medicine, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue40.5M32.3M78.1M19.7M25.5M90.7M20.5M31.9M13.7M6.05M
Cost of revenue5.28M199.2M6.06M6.34M5.05M158.0M96.9M90.7M83.2M57.0M
Gross profit40.5M-166.9M72.1M19.7M25.5M90.7M-76.4M-58.7M-69.4M-50.9M
Research and development90.0M199.2M177.7M175.0M142.5M158.0M96.9M90.7M83.2M57.0M
Selling, general and administrative49.9M72.0M69.7M70.7M76.2M67.6M64.6M55.0M50.5M46.3M
Operating income-160.0M-251.2M-169.2M-225.9M-193.1M-134.8M-140.9M-113.7M-119.9M-97.2M
Depreciation and amortization5.28M5.81M6.06M6.34M5.05M3.96M2.83M3.25M2.68M1.20M
EBITDA-154.7M-245.3M-163.1M-219.6M-188.1M-130.9M-138.1M-110.5M-117.3M-96.0M
Interest expense2.13M04.22M5.70M2.60M7.31M3.44M978.0K62.0K
Income before tax-160.1M-237.1M-153.2M-220.4M-192.5M-116.0M-133.7M-110.0M-120.3M-97.2M
Income tax00000-6.56M-10.3M-3.12M-1.12M-1.32M
Net income-160.1M-237.1M-153.2M-220.4M-192.5M-116.0M-133.7M-110.0M-120.3M-97.2M
Earnings per share, basic-1.80-2.88-2.02-3.21-2.85-1.98-2.68-2.33-2.98-3.02
Earnings per share, diluted-1.80-2.88-2.02-3.21-2.85-1.98-2.68-2.33-2.98-3.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents146.6M131.5M123.7M141.5M203.5M139.7M238.2M134.8M146.6M185.3M
Short-term investments0138.4M199.5M202.8M296.3M262.4M219.0M234.2M182.5M0
Receivables15.2M16.3M10.2M5.14M267.0K6.05M418.0K30.0K679.0K88.0K
Inventory-93.1M-120.1M-109.7M2.92M1.86M1.66M
Current assets163.9M289.3M340.8M356.8M507.3M419.1M463.8M374.8M332.2M187.2M
Property, plant and equipment3.54M14.5M12.0M15.6M17.1M14.0M10.9M40.2M39.4M40.4M
Goodwill00
Total assets186.5M341.6M499.2M514.3M677.5M572.6M508.9M420.4M373.3M229.2M
Accounts payable2.60M5.49M8.27M9.51M5.05M6.41M5.84M5.33M4.02M4.64M
Current liabilities46.2M77.2M63.2M60.1M46.9M58.2M60.0M35.9M36.7M33.1M
Long-term debt53.6M52.4M033.4M35.1M
Total debt58.6M57.4M043.9M26.4M26.1M29.1M45.2M40.9M45.1M
Total liabilities159.2M207.3M150.1M153.6M123.8M179.0M246.4M184.2M165.2M94.6M
Shareholders' equity27.3M134.3M349.1M360.7M553.6M393.6M262.4M236.2M208.1M134.6M
Shares outstanding97.9M82.7M81.8M68.8M68.4M62.6M54.4M48.8M44.5M35.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-165.2M-210.3M-132.2M-177.3M-163.8M-179.8M-40.7M-45.7M-9.42M-50.2M
Capital spending-607.0K-8.83M-4.72M-4.12M-7.98M-7.16M-6.17M-4.75M-2.06M-3.49M
Free cash flow-165.8M-219.1M-136.9M-181.5M-171.8M-187.0M-46.8M-50.5M-11.5M-53.7M
Cash from investing138.7M162.1M-3.73M114.1M-54.5M-140.5M12.3M-53.1M-183.8M-3.47M
Cash from financing40.5M56.0M118.0M1.28M282.1M224.1M131.8M86.9M154.5M97.2M
Dividends paid-4.00K-11.0K-782.0K
Share buybacks1.28M282.1M224.1M131.8M4.00K11.0K11.0K
Change in cash13.9M7.89M-17.9M-62.0M63.8M-96.2M103.4M-11.9M-38.7M43.4M